Finland· FI-REL-REL34301
Candexetil
A candesartan product containing candesartan cilexetil, registered in Finland by ratiopharm GmbH. The same ATC class is registered in 16 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Candesartan is registered in 16 of 19 countries.
Countries holding a registration under ATC C09CA06 (candesartan), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 9 of them publish a price we can compare per daily dose
Candesartan · ATC C09CA06
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of candesartan costs, country by country.
Normalised to the WHO defined daily dose (8 mg), the median price runs from $0.15 in Italy to $0.36 in Switzerland — a ×2.3 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Candesartan · price per daily dose (8 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.36
- ES Spain$0.21
- IT Italy$0.15
The record
At a glance
Fimea (Finland)- Active substance
- Candesartan cilexetil
- Manufacturer
- ratiopharm GmbH
- Country
- Finland (FI)
- ATC code
- C09CA06
- ATC class
- Candesartan
- Defined daily dose
- 8 mg, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 2
2 priced- fi_myyntilupa12890628EUR 4.57
- fi_myyntilupa05206798EUR 2.47
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
81 interactions on record for candesartan.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Candesartan · interactions on record
81 records
81 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Candesartan in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCANOCORDKrka, d.d., Novo mesto, Novo mesto
- FranceATACAND 8 mg, comprimé sécableCHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
- CanadaACH-CANDESARTANACCORD HEALTHCARE INC
- ItalyBLOPRESSMEDIFARM S.R.L.
- SwedenAtacand 8 mg TablettCheplapharm Arzneimittel GmbH
- United StatesATACANDANI Pharmaceuticals, Inc.
- IrelandAtacand 8 mg tabletsPCO Manufacturing Ltd.
- NorwayAtacandOrifarm AS
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Atacand, Blopress
- Belgium · Atacand, Candesartan Eg
- Bulgaria · Атаканд, Кандекон
- Cyprus · Atacand, Candepress
- Czechia · Canocord, Carzap
- Germany · Atacand, Atacand Protect
- Denmark · Atacand, Candemox
- Estonia · Atacand, Canocord
- Spain · Atacand, Blopress
- France · Atacand, Candesartan Arrow
- United Kingdom (Northern Ireland) · Amias, Atacand
- Greece · Atacand, Fyronexe
- Croatia · Kandepres, Kandepres 16
- Hungary · Karbis
- Ireland · Atacand, Blopress
- Iceland · Candesartan Stada, Candpress
- Italy · Blopress, Candesartan Alter
- Lithuania · Canocord, Carzan
- Luxembourg · Atacand, Candesartan Eg
- Latvia · Canocord, Carzan
- Malta · Candesartan, Candesartan Cilexetil Aurobindo Pharma (Malta)
- Netherlands · Atacand, Candesartan Cilexetil Aurobindo
- Norway · Atacand, Candesartan Krka
- Poland · Atacand, Candepres
- Portugal · Atacand, Blopress
- Romania · Atacand, Candesartan
- Sweden · Atacand, Canderion
- Slovenia · Atacand, Candea
- Slovakia · Atacand, Candesartan Ratiopharm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ff83ae68-cc2f-4f00-83f6-ff64c5743895 GET /v1/drugs/ff83ae68-cc2f-4f00-83f6-ff64c5743895?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "8",
"form": "tabletti",
"route": "Suun kautta",
"ddd_unit": "mg",
"strength": "8 mg",
"atc_label": "kandesartaani",
"ma_number": "27175",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL34301",
"authorised_at": "2010-07-21"
}See everything about candesartan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.